Keywords: فعالیت Opsonophagocytic; PPV23; pneumococcal polysaccharide vaccine; PCV7; pneumococcal conjugate vaccine; IPD; invasive pneumococcal disease; ANCA; antineutrophil cytoplasmic antibody; PR3-ANCA; ANCA directed against proteinase 3; MPO-ANCA; ANCA directed against myeloperoxidase;
مقالات ISI فعالیت Opsonophagocytic (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فعالیت Opsonophagocytic; AE; adverse event; ClfA; clumping factor A; cLIA; four-plex competitive Luminex® immunoassay; CI; confidence interval; CP; capsular polysaccharide; CRM197; diphtheria toxin; DMC; data monitoring committee; FBI; fibrinogen-binding inhibition; FDA; Food an
Keywords: فعالیت Opsonophagocytic; AE; adverse event; CAP; community-acquired pneumonia; GMFR; geometric mean fold rise; GMT; geometric mean titer; IPD; invasive pneumococcal disease; OPA; opsonophagocytic activity; PCV13; 13-valent pneumococcal conjugate vaccine; PPSV23; 23-valent pneumoc
Keywords: فعالیت Opsonophagocytic; Serotype-specific IgG; Opsonophagocytic activity; Pneumococcal polysaccharide vaccine; Revaccination;
Keywords: فعالیت Opsonophagocytic; AE; adverse event; CI; confidence interval; CRM197; cross-reactive material 197; GMR; geometric mean ratio; GMT; geometric mean titer; IPD; invasive pneumococcal disease; LLOQ; lower limit of quantitation; LOD; limit of detection; OPA; opsonophagocytic ac
Keywords: فعالیت Opsonophagocytic; ACIP; United States Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; CRM197; cross-reactive material 197; GMR; geometric mean ratio; GMT; geometric mean titer; OPA; opsonophagocytic activity; PCV; pneumococcal poly
Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III
Keywords: فعالیت Opsonophagocytic; Pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV); 1-dose vial presentation; 4-dose vial presentation; Immunologic non-inferiority; Safety; Infants; AE; adverse event; ATP; according-to-protocol; CI; confidence interva
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2-17-year-old children with asplenia or splenic dysfunction: A phase 3 study
Keywords: فعالیت Opsonophagocytic; Pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV); Immunogenicity; Safety; Asplenia; Splenic dysfunction; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay
Memory B cell response to a PCV-13 booster in 3.5Â year old children primed with either PCV-7 or PCV-13
Keywords: فعالیت Opsonophagocytic; ASC; antibody secreting cells; BCR; B cell receptor; BMEM; memory B cells; GC; germinal centre; LLD; lower limit of detection; MenC; group C meningococcus; OPA; opsonophagocytic activity; PBMCs; peripheral blood mononuclear cells; PBS; phosphate buffered
Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women
Keywords: فعالیت Opsonophagocytic; Antibody; colonization; group B Streptococcus; opsonophagocytic activity; pregnant women;
A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults
Keywords: فعالیت Opsonophagocytic; Staphylococcus aureus; Vaccine; Functional antibodies; Capsule proteins; Clinicaltrials.gov Identifier. NCT01018641; AE; adverse event; ClfA; clumping factor A; cLIA; competitive Luminex® immunoassay; CP; capsular polysaccharide; CP5; capsular polysaccha
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study
Keywords: فعالیت Opsonophagocytic; 23PPV; 23-valent pneumococcal polysaccharide vaccine; AE; adverse event; anti-PD; NTHi protein D antibody; ATP; according to protocol; dPly; pneumolysin toxoid; ELISA; enzyme-linked immunosorbent assay; GMC; geometric mean concentration; GMT; geometric me
Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial
Keywords: فعالیت Opsonophagocytic; Pneumococcal proteins; dPly; PhtD; Safety; Immunogenicity; Toddler vaccination; AE; adverse event; anti-PD; NTHi protein D antibody; ATP; according-to-protocol; CI; confidence interval; dPly; pneumolysin toxoid; ELISA; enzyme-linked immunosorbent assay; G
Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged â¥65 years
Keywords: فعالیت Opsonophagocytic; 13-Valent pneumococcal conjugate vaccine; Trivalent inactivated influenza vaccine; Opsonophagocytic activity; Noninferiority;
Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease
Keywords: فعالیت Opsonophagocytic; Invasive pneumococcal disease; Serotype-specific IgG; Opsonophagocytic activity; Pneumococcal vaccine; Children;
Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamo
Keywords: فعالیت Opsonophagocytic; AE; adverse event; ATP; according-to-protocol; BS; blood sample; CPS; capsular polysaccharide; CI; confidence interval; DTPa-HBV-IPV/Hib; combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae
Preclinical immunogenicity and functional activity studies of an AÂ +Â W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines
Keywords: فعالیت Opsonophagocytic; Neisseria meningitidis; Meningococcal disease; Vaccine; Outer membrane protein; Outer membrane vesicle; OMV; Africa; Meningitis belt; Serum bactericidal activity; SBA; Opsonophagocytic activity; OPA;
The potential cost-effectiveness of infant pneumococcal vaccines in Australia
Keywords: فعالیت Opsonophagocytic; 3Â +Â 0; vaccine dose schedule of 3 infant doses without toddler booster dose; 3Â +Â 1; vaccine dose schedule of 3 infant doses and one toddler dose; AIHW; Australian Institute of Health and Welfare; AR-DRG; Australian refined-diagnosis related group; BEA
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age
Keywords: فعالیت Opsonophagocytic; Pneumococcal vaccination; Opsonophagocytic activity
Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults
Keywords: فعالیت Opsonophagocytic; Chimerized monoclonal antibody; Safety; Pharmacokinetics; Opsonophagocytic activity; Immunogenicity; Staphylococcus aureus; Staphylococcus epidermidis; Coagulase negative staphylococci
Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly
Keywords: فعالیت Opsonophagocytic; Pneumococcal vaccine; Antibody concentration; Opsonophagocytic activity
Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine
Keywords: فعالیت Opsonophagocytic; Pneumococcal conjugate vaccine; Opsonophagocytic activity